Abstract
AIMS: Childhood cancer therapy is associated with a significant risk of therapy-related cardiotoxicity. This meta-analysis aims to evaluate cardiac biomarkers for the detection of cancer therapy-related left ventricular (LV) dysfunction in childhood cancer patients.
METHODS AND RESULTS: PubMed, Cochrane Library, Wiley Library, and Web of Science were screened for studies investigating brain natriuretic peptide (BNP)/N-terminal proBNP (NT-proBNP) or cardiac troponin in childhood cancer patients. The odds ratios (OR) for elevation of cardiac biomarkers and association with LV dysfunction were calculated using a random-effects model. Data from 27 studies with 1651 subjects were included. BNP/NT-proBNP levels were higher post-treatment compared with controls or pre-treatment values [standardized mean difference = 1.0; 95% confidence interval (CI) = 0.6-1.4; n = 320; P < 0.001].
CONCLUSIONS: BNP/NT-proBNP is associated with cardiotoxicity in paediatric cancer patients receiving anthracycline therapy, but owing to low sensitivity, BNP/NT-proBNP has to be evaluated in the context of further parameters including clinical assessment and echocardiography. Future studies are needed to determine whether troponin serves as a marker for cardiotoxicity in children. Standardized recommendations for the application of cardiac biomarkers in children undergoing cardiotoxic cancer therapy may benefit management and clinical outcome.
PMID: 32069386 [PubMed - as supplied by publisher]
15:27
Photo
Not included, change data exporting settings to download.
256×256, 6.0 KB
15:27
In reply to this message
pubmed: ctoall&ca or conall
Inflammation begets inflammation: cancer and acute MI.
Inflammation begets inflammation: cancer and acute MI.
Eur Heart J. 2020 Feb 18;:
Authors: Kondapalli L, Moslehi J, Bonaca MP
PMID: 32068786 [PubMed - as supplied by publisher]
15:27
Photo
Not included, change data exporting settings to download.
256×256, 6.0 KB
15:27
In reply to this message
pubmed: ctoall&ca or conall
Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat.
Cardiotoxicity in Hematopoietic Stem Cell Transplant: Keeping the Beat.
Clin Lymphoma Myeloma Leuk. 2020 Jan 18;:
Authors: Baker JK, Shank-Coviello J, Zhou B, Dixon J, McCorkle R, Sarpong D, Medoff E, Cooper D, Seropian S, Dai F
No comments:
Post a Comment
اكتب تعليق حول الموضوع